Wang H - Search Results

1

Current status and quality of radiomics studies in lymphoma: a systematic review.

Wang H, Zhou Y, Li L, Hou W, Ma X, Tian R. Wang H, et al. Eur Radiol. 2020 Nov;30(11):6228-6240. doi: 10.1007/s00330-020-06927-1. Epub 2020 May 29. Eur Radiol. 2020. PMID: 32472274

2

Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis.

Wang H, Shen G, Jiang C, Li L, Cui F, Tian R. Wang H, et al. PLoS One. 2018 Mar 20;13(3):e0194435. doi: 10.1371/journal.pone.0194435. eCollection 2018. PLoS One. 2018. PMID: 29558489 Free PMC article.

3

Uterine Corpus Metastasis From Rectal Adenocarcinoma Detected Using 18F-FDG PET/CT.

Wang H, Su M, Cui F, Wu X, Tian R. Wang H, et al. Clin Nucl Med. 2018 Aug;43(8):614-616. doi: 10.1097/RLU.0000000000002167. Clin Nucl Med. 2018. PMID: 29916919

4

Development and validation of an ¹⁸F-FDG PET radiomic model for prognosis prediction in patients with nasal-type extranodal natural killer/T cell lymphoma.

Wang H, Zhao S, Li L, Tian R. Wang H, et al. Eur Radiol. 2020 Oct;30(10):5578-5587. doi: 10.1007/s00330-020-06943-1. Epub 2020 May 20. Eur Radiol. 2020. PMID: 32435928

5

Assessment of the prognostic value of interim fluorodeoxyglucose positron emission tomography/computed tomography in nasal-type extranodal natural killer/T-cell lymphoma.

Chen X, Zhao S, Wang H, Fu C, Tian R, Zou L. Chen X, et al. Among authors: wang h. Quant Imaging Med Surg. 2021 Apr;11(4):1220-1233. doi: 10.21037/qims-20-620. Quant Imaging Med Surg. 2021. PMID: 33816162 Free PMC article.

6

Investigating ¹⁸F-FDG PET/CT Parameters as Prognostic Markers for Differentiated Thyroid Cancer: A Systematic Review.

Wang H, Dai H, Li Q, Shen G, Shi L, Tian R. Wang H, et al. Front Oncol. 2021 May 13;11:648658. doi: 10.3389/fonc.2021.648658. eCollection 2021. Front Oncol. 2021. PMID: 34055616 Free PMC article.

7

Quantifying the contribution of ¹⁸F-FDG PET to the diagnostic assessment of pediatric patients with fever of unknown origin: a systematic review and meta-analysis.

Li Q, Tian R, Wang H, Li L, Wu T, Ren Y, Su M, Zou K, Sun X. Li Q, et al. Among authors: wang h. Pediatr Radiol. 2022 Jul;52(8):1500-1511. doi: 10.1007/s00247-022-05333-7. Epub 2022 Mar 29. Pediatr Radiol. 2022. PMID: 35348809

8

The association between the interval of radioiodine treatment and treatment response, and side effects in patients with lung metastases from differentiated thyroid cancer.

Wang H, Shi L, Huang R, Liu B, Tian R. Wang H, et al. Front Endocrinol (Lausanne). 2023 May 31;14:1117001. doi: 10.3389/fendo.2023.1117001. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37324277 Free PMC article.

9

Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.

Wang H, Zhang C, Li Q, Tian T, Huang R, Qiu J, Tian R. Wang H, et al. BMC Cancer. 2024 Apr 8;24(1):427. doi: 10.1186/s12885-024-12146-4. BMC Cancer. 2024. PMID: 38589799 Free PMC article.

10

Improving the Risk Prediction of the 2015 ATA Recurrence Risk Stratification in Papillary Thyroid Cancer.

Wang H, Li Q, Tian T, Liu B, Tian R. Wang H, et al. J Clin Endocrinol Metab. 2025 Jan 21;110(2):534-541. doi: 10.1210/clinem/dgae465. J Clin Endocrinol Metab. 2025. PMID: 38980946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152,735 results

Search Page

Filters